About Arix Bioscience
Arix Bioscience is a company based in London (United Kingdom) founded in 2016 was acquired by RTW Investments in November 2023. The company has 331 employees.
- Headquarter London, United Kingdom
- Employees 331
- Stage Public
- SectorsFinancial Services
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website arixbioscience.com
- Social LinkedIn X Facebook
- Acquired by RTW Investments (Nov 2023)
- Annual Revenue$138.53 K (USD)-67as on Dec 31, 2022
- Net Profit-$34.11 M (USD)55as on Dec 31, 2022
- EBITDA-$34.11 M (USD)55as on Dec 31, 2022
- Latest Funding Round$4.92M (USD), Post-IPO
Mar 2018
- Investors
- Employee Count331
- Acquired byRTW Investments
(Nov 2023)
Funding Insights of Arix Bioscience
- Total Rounds 2
- Last Round Post-IPO — $4.92M
- First Round $17.94M
(Mar 2017)
All 2 funding rounds of Arix Bioscience with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2018 | $4.92M | Post-IPO | – | – | – |
| Mar 2017 | $17.94M | Post-IPO | – | – | – |
1 investors in total: 1 institutional.
Investors in Arix Bioscience
Arix Bioscience has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include RTW Investments.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Life Sciences focused VC firm investing in the US | 2010 | rtwfunds.com | New York, United States |
Investor details for Arix Bioscience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Arix Bioscience
12 people are tracked at Arix Bioscience (5 in leadership, 3 in board & advisors, 4 in team); the tracked headcount is 331.
| Name | Role | Group |
|---|---|---|
Tassos Konstantinou | Managing Director | Leadership |
Peregrine Moncreiffe | Chairman | Leadership |
Robert Lyne | CEO | Leadership |
Mark Chin | Managing Director | Leadership |
Tom Davidson | Finance Director | Leadership |
Debra Barker | Senior Independent Director | Board & advisors |
Isaac Kohlberg | Non-Executive Director | Board & advisors |
Maureen O’Connell | Non-Executive Director | Board & advisors |
Laura Craig | Investor Relations Officer | Team |
Felix Breyer | Associate | Team |
Roy Bartel-Taverner | Analyst | Team |
Jade Fletcher | Financial Controller | Team |
Complete people profiles for Arix Bioscience
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Arix Bioscience
5 dated milestones of Arix Bioscience across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Arix Bioscience is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $17.9M.
- Funding Latest funding round, Post-IPO, of $4.9M.
- Exit Acquired by RTW Investments.
Web traffic of Arix Bioscience
The website of Arix Bioscience (arixbioscience.com) receives about 1K visits a month and ranks #13,259,779 among all websites worldwide, #8,400 in Biotechnology and Pharmaceuticals.
- Monthly visits1K
▼ 11.6% vs previous month
- Global rank#13,259,779
among all websites
- Category rank#8,400
Health · Biotechnology and Pharmaceuticals
- Bounce rate43%
- Pages per visit1.3
- Average visit13 sec
- DevicesDesktop 21% · Mobile 79%
Latest news on Arix Bioscience
Complete news archive for Arix Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Arix Bioscience
10 companies that operate in the same segment as Arix Bioscience (Venture Capital Funds), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Network connecting investors to startups, venture capital funds, and alternatives | 2013 | Jerusalem, Jerusalem District, Israel | USD 35 M | – | – | |
Venture capital firm investing in early-stage tech startups | 1972 | Menlo Park, California, United States | USD 1.2 B | – | – | |
Venture capital investments and support for entrepreneurs in technology and innovation sectors. | 1911 | Redwood City, California, United States | – | USD 691.23 K | – | |
Accel is recognized as a leading venture capital firm. | 1983 | Palo Alto, California, United States | – | – | – | |
Early-stage startup ecosystem is supported by Venture Catalysts in India. | 2015 | Mumbai, Maharashtra, India | – | USD 3.32 M | – | |
Venture capital investing in innovative companies across global sectors is undertaken by Lightspeed Venture Partners. | 1997 | Menlo Park, California, United States | – | – | 42 | |
Venture capital fund and startup incubator for healthcare and agricultural companies | 1993 | Misgav, Northern District, Israel | – | USD 1.99 M | 23 | |
Management consulting services are provided to organizations worldwide. | 1965 | Brisbane, Queensland, Australia | – | – | – | |
Multiple sectors are invested in by this venture capital firm. | 1987 | Sao Paulo, Brazil | – | USD 715.62 M | – | |
Early-stage startups are funded by this venture capital firm. | 2004 | Menlo Park, California, United States | – | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Arix Bioscience
Arix Bioscience was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Arix Bioscience is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Robert Lyne is the current CEO of Arix Bioscience.
Arix Bioscience has 331 employees.
Annual revenue of Arix Bioscience is $138.53K as on Dec 31, 2022.
Arix Bioscience was founded in 2016 as a venture capital fund based in London, United Kingdom. Focus is placed on the life sciences sector, where investments are directed toward biotech companies. Operations involve funding and developing startups in biotechnology. Support is provided for building innovative firms within this domain, with activities centered on early-stage opportunities in the industry.
Arix Bioscience has 1 investor. Key investors include RTW Investments.
Yes. Arix Bioscience was acquired by RTW Investments in November 2023.